Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 149pembrolizumab 130Magnetic Resonance Spectroscopy 120Cyclophosphamide 117Biopsy 102fludarabine 89Nivolumab 58Carboplatin 53Cisplatin 48Radiotherapy 46Gemcitabine 46venetoclax 43Paclitaxel 41Cetuximab 41fludarabine phosphate 39Ipilimumab 35atezolizumab 34Fluorouracil 34Bevacizumab 33durvalumab 29Radiation 28Oxaliplatin 28Leucovorin 28Dexamethasone 28X-Rays 26Irinotecan 26Cytarabine 26Azacitidine 26Radiosurgery 24Injections 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × C188-9 compound × 90 days × Clear all
NCT06141031 2026-05-27

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Washington University School of Medicine

Phase 1 Recruiting
18 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡